Grantham, Mayo, Van Otterloo & Co (GMO)’s Axalta AXTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Buy
+323,578
New +$9.73M 0.02% 246
2020
Q2
Sell
-1,532,501
Closed -$26.5M 751
2020
Q1
$26.5M Buy
1,532,501
+697,057
+83% +$17.8M 0.22% 71
2019
Q4
$25.4M Buy
+835,444
New +$24.6M 0.17% 100

Other funds holding AXTA

Grantham, Mayo, Van Otterloo & Co (GMO)'s AXTA Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Axalta (AXTA) in Q2 2026: 323,578 shares worth $11.1M. The stake represents 0.02% of the portfolio and ranks #246 among its holdings. This is a return to the name: Grantham, Mayo, Van Otterloo & Co (GMO) previously reported a position in AXTA as recently as Q1 2020.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AXTA in Q4 2019 and has held it in 3 quarters since. The position peaked at $26.5M in Q1 2020. 362 funds tracked by Wall St. Rank hold AXTA as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 323,578 shares of Axalta worth $11.1M as of Q2 2026.
  • Axalta was a new Grantham, Mayo, Van Otterloo & Co (GMO) position in Q2 2026.
  • Axalta made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #246 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Axalta in Q4 2019 and has held it in 3 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Axalta position peaked at $26.5M in Q1 2020.
  • 362 funds tracked by Wall St. Rank held Axalta as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.